For patients taking herbal therapy - Lessons from aristolochic acid nephropathy

Nephrology Dialysis Transplantation

Volumn 22, Issue 6, 2007, Pages 1512-1517

  Nortier, Joëlle L ^a   Vanherweghem, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Aristolochia; Complementary and alternative medicine; Herbal remedies; Toxic nephropathy

Indexed keywords

AKEBIA EXTRACT; ARISTOLOCHIA CLEMATIS EXTRACT; ARISTOLOCHIA CONTORTA EXTRACT; ARISTOLOCHIA DEBILIS EXTRACT; ARISTOLOCHIA FANGCHI EXTRACT; ARISTOLOCHIA MANSHURIENSIS EXTRACT; ARISTOLOCHIC ACID; ASARUM EXTRACT; AYURVEDIC DRUG; CLEMATIS EXTRACT; COCCULUS EXTRACT; CORTICOSTEROID; DEXFENFLURAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; KAMPO; MAGNOLIA OFFICINALIS EXTRACT; OCHRATOXIN; PLANT EXTRACT; STEPHANIA TETRANDRA EXTRACT; TETRANDRINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AKEBIA; ANEMIA; ARISTOLOCHIA; ARISTOLOCHIA CLEMATIS; ARISTOLOCHIA CONTORTA; ARISTOLOCHIA DEBILIS; ARISTOLOCHIA MANSHURIENSIS; ARTHRALGIA; ASARUM; ASTHMA; ATROPHY; CARCINOGENICITY; CHINESE MEDICINE; CHRONIC KIDNEY FAILURE; CLEMATIS; COCCULUS; COUGHING; DRUG CONTROL; DRUG EFFICACY; DRUG INDICATION; DRUG QUALITY; DRUG SAFETY; DRUG TREATMENT FAILURE; EDEMA; FANCONI RENOTUBULAR SYNDROME; GASTROINTESTINAL DISEASE; HEADACHE; HEMODIALYSIS; HEMORRHOID; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; INSECT BITE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SIDE EFFECT; SNAKEBITE; ULCER; URINARY TRACT CARCINOMA; URINARY TRACT INFECTION; URINE SEDIMENT; UROGENITAL TRACT TUMOR; UROLOGIC SURGERY;

ANIMALS; ARISTOLOCHIC ACIDS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; PHYTOTHERAPY;

EID: 34447566285     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm167     Document Type: Review

References (55)

1. Strauss SE. Herbal Medicine: What's in the bottle ? N Engl J Med 2002; 347: 1997-1998
2. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569-1575
3. Marcus DM, Grollman AP. Botanical medicines. The need for new regulations. N Engl J Med 2002; 347: 2073-2076
4. De Smet PAGM. Herbal Medicine in Europe. Relaxing regulatory standards. N Engl J Med 2005; 352: 1176-1178
5. Vivekanand J, Chugh KS. Nephropathy associated with animal, plant, and chemical toxins in the tropics, Semin Nephrol 2003; 23: 49-65
6. Isnard-Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherveghem JL. Herbs and the kidney. Am J Kidney Dis 2004; 44: 1-11
7. Huxtable RJ. The myth of beneficient nature: The risks of herbal preparations. Ann Intern Med 1992; 117: 165-166
8. Varner JS. Green medicine, muddy water. J Altern Complement Med 2001; 7: 361-370
9. International Agency for Research on Cancer (IARC). Some traditional herbal medicines, some mycotoxins, naphtalene and styrene. In: IARC Monographs on the Evaluation of Carcinogenic Risks of Chemical to Humans IARC, Lyon, France: 2002; 82
10. Vanherweghem JL. Aristolochia sp and chronic interstitial nephropathies in Indians. Lancet 1997; 349: 1399
11. Che C-T, Ahmed MS, Kang SS et al. Studies on Aristolochia III. Isolation and biological evaluation of constituents of Aristolochia indica roots for fertility-regulating activity. J Nat Prod 1984; 47: 331-341
12. Vanherweghem JL, Depierreux M, Tielemans C et al. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-391
13. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343: 174
14. Schmeiser HH, Bieler C, Wiessler M et al. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56: 2025-2028
15. Nortier JL, Muniz Martinez MC, Schmeiser HH et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342: 1686-1692
16. Reginster F, Jadoul M, Van Ypersele de Strihou C. Chinese herb nephropathy: Presentation, natural history and fate after transplantation. Nephrol Dial Transplant 1997; 12: 81-86
17. Vanherweghem JL, Debelle F, Muniz Martinez MC, Nortier JL. Aristolochic acid nephropathy after Chinese herbal remedies. In: De Broe ME, Porter GA, Bennett WM and Verpooten GA, eds. Clinical Nephrotoxins, 2nd edn., Karger, London, UK: 2003; 579-586
18. Van Ypersele de Strihou C and Vanherweghem JL. The tragic paradigm of Chinese herb nephropathy. Nephrol Dial Transplant 1995; 10: 157-160
19. Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, Van Ypersele de Strihou C. Chinese herbs nephropathy: A clue to Balkan endemic nephropathy ? Kidney Int 1994; 45: 1680-1688
20. Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994; 24: 172-180
21. Kabanda K, Jadoul M, Lauwerys R, Bernard A, Van Ypersele de Strihou C. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995; 48: 1571-1576
22. Nortier JL, Deschodt-Lanckman MM, Simon S et al. Proximal tubular injury in Chinese herbs nephropathy: Monitoring by neutral endopeptidase enzymuria. Kidney Int 1997; 51: 288-293
23. Vanherweghem JL. Urémie chronique et cancer des voies urinaires secondaires à la prise d'extraits végétaux utilisés en phytothérapie chinoise. Médecine/Sciences 2002; 18: 1095-1101
24. Lo SH, Mo KL, Wong KS et al. Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2004; 19: 1913-1915
25. Jadoul M, De Plaen JF, Cosyns JP, Van Ypersele de Strihou C. Adverse effects from traditional Chinese medicines. Lancet 1993; 341: 892-893
26. Richter S, Flesch F, Fisher E et al. Hydronéphrose bilatérale consécutive à la prise d'herbes chinoises: Enjeu diagnostique et thérapeutique. Néphrologie 2002; 23: 274
27. Muniz Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. Progression rate of Chinese herb nephropathy: Impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002; 17: 408-412
28. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: A pilot studying Chinese herbs. Am J Kidney Dis 1996; 27: 209-215
29. Cosyns JP, Jadoul M, Squifflet JP, Van Cangh PJ, Van Ypersele de Strihou C. Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 1994; 344: 188
30. Vanherweghem JL, Tielemans C, Simon J, Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant 1995; 10: 270-273
31. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001; 358: 1515-1516
32. Cosyns JP, Jadoul M, Squifflet JP, Wese F-X, Van Ypersele de Strihou C. Urothelial lesions in Chinese herb nephropathy. Am J Kidney Dis 1999; 33: 1011-1017
33. Buell JF, Thomas G, Gross E, Woodle S. Malignancy after transplantation. Transplantation 2005; 80: 254-264
34. Penn I. Post-transplant malignancy: The role of immunosuppression. Drug Saf 2000; 23: 101-113
35. Stefanovic V, Polenakovic MH. Balkan nephropathy: Kidney disease beyond the Balkan? Am J Nephrol 1991; 11: 1-11
36. Nortier JL, Schmeiser HH, Muniz Martinez MC et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 2003; 18: 426-428
37. Laing C, Hamour S, Sheaff M, Miller R, Woolfson R. Chinese herbal uropathy and nephropathy. Lancet 2006; 368: 338
38. Mengs U, Lang W, Poch J-A. The carcinogenic action of aristolochic acid in rats. Arch Toxicol 1982; 51: 107-119
39. Schmeiser HH, Pool BL, Wiessler M. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis 1986; 7: 59-63
40. Pezzuto JM, Swanson SM, Mar W et al. Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylene-dioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives. Mut Res 1988; 206: 447-454
41. Stiborova M, Frei E, Wiesler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: Evidence for reductive activation by cytochrome P450 1A1 and 1A2, Chem Res Toxicol 2001; 14: 1128-1137
42. Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase - (32)P-labeling analysis of DNA adduct formation. Mut Res 2001; 493: 149-160
43. Schmeiser HH, Scherf HR, Wiessler M. Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice. Cancer Lett 1991; 59: 139-143
44. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human hazard in herbal remedies: A review. Mutagenesis 2002; 17: 265-277
45. Lebeau C, Arlt VM, Schmeiser HH et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int 2001; 60: 1332-1342
46. Lebeau C, Debelle F, Arlt VM et al. Early proximal tubule injury in experimental aristolochic acid nephropathy: Functional and histological studies. Nephrol Dial Transplant 2005; 20: 2321-2332
47. Belachadran P, Wei F, Lin R-C, Khan IA, Pasco DS. Structure activity relationships of aristolochic analogues: Toxicity in cultured renal epithelial cells. Kidney Int 2005; 67: 1797-1805
48. Cosyns JP, Goebbels RM, Liberton V, Schmeiser HH, Bieler CA, Bernard AM. Chinese herbs nephropathyassociated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats. Arch Toxicol 1998; 72: 738-743
49. Cosyns JP, Dehoux JP, Guiot Y et al. Chronic aristolochic acid toxicity in rabbits: A model of Chinese herb nephropathy? Kidney Int 2001; 59: 2164-2173
50. Debelle F, Nortier JL, De Prez E et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt depleted rats. J Am Soc Nephrol 2002; 13: 431-436
51. Debelle F, Nortier JL, Arlt VM et al. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese herb nephropathy. Arch Toxicol 2003; 77: 218-226
52. Debelle FD, Nortier JL, Husson CP et al. The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int 2004; 66: 1815-1825
53. Food and Drug Administration. Dietary supplements: Aristolochic acid (accessed 25 September 2003, at http://www.cfsan.fda.gov/~dms/ ds-bot.html).
54. Gold LS, Slone TH. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert. N Engl J Med 2003; 349: 1576-1577
55. Vanherweghem JL. Nephropathy and herbal medicine. Am J Kidney Dis 2000; 35: 330-332